GENEVA, May 12 -- MEDSYD AB (Farinvagen 924533 Staffanstorp) filed a patent application (PCT/SE2025/010014) for "OIL-BASED VITAMIN B12 SUSPENSION FOR ORAL ADMINISTRATION ACROSS VARIOUS AGE GROUPS" on Oct 22, 2025. With publication no. WO/2026/095847, the details related to the patent application was published on May 07, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): VIBERG, Cedric (Farinvagen 924533 Staffanstorp), PERSSON, Peter (Stabbarp 45724192 Eslov)
Abstract: The invention relates to an oil-based suspension of vitamin B12 formulated for oral administration, primarily intended for infa...